BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18521496)

  • 41. [The impact of thromboprophylaxis with enoxaparin on bleeding rate in rejuvenating facelift procedures].
    Kuz'min VV; Buzov DA; Nudel'man SV; Golubkov NA
    Khirurgiia (Mosk); 2014; (7):66-71. PubMed ID: 25146545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous thromboembolism prophylaxis and wound healing in patients undergoing major orthopedic surgery.
    Snyder BJ; Waldman BJ
    Adv Skin Wound Care; 2009 Jul; 22(7):311-5. PubMed ID: 20375968
    [No Abstract]   [Full Text] [Related]  

  • 43. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.
    Gerlach R; Scheuer T; Beck J; Woszczyk A; Seifert V; Raabe A
    Neurosurgery; 2003 Nov; 53(5):1028-34; discussion 1034-5. PubMed ID: 14580268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How long to anticoagulate?
    Thachil J
    QJM; 2014 Jun; 107(6):495-7. PubMed ID: 24729263
    [No Abstract]   [Full Text] [Related]  

  • 46. Rivaroxaban versus enoxaparin after total knee arthroplasty.
    Gómez-Outes A; Suárez-Gea ML; Blázquez-Pérez A; Pozo-Hernández C; Vargas-Castrillón E
    Lancet; 2009 Aug; 374(9691):682; author reply 683. PubMed ID: 19716955
    [No Abstract]   [Full Text] [Related]  

  • 47. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Summary and perspectives. Rivaroxaban].
    Albaladejo P
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin.
    Prandoni P; Cattelan AM; Carrozzi L; Leone L; Filippi L; De Gaudenzi E; Villalta S; Pesavento R;
    Thromb Res; 2020 Dec; 196():395-397. PubMed ID: 33007739
    [No Abstract]   [Full Text] [Related]  

  • 50. Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis Following Robot-assisted Radical Cystectomy: A Retrospective Feasibility Study at a Single Academic Medical Center.
    Ortiz RM; Golijanin B; O'Rourke TK; Sobel DW; Pillsbury L; T Tucci C; Caffery P; Golijanin D
    Urology; 2021 Oct; 156():154-162. PubMed ID: 34171347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic bleeding in a patient with enoxaparin-induced thrombocytopenia.
    Famularo G; Gasbarrone L; Minisola G; De Simone C
    Am J Emerg Med; 2009 Jul; 27(6):756.e1-2. PubMed ID: 19751647
    [No Abstract]   [Full Text] [Related]  

  • 52. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of venous thromboembolism in orthopedic surgery.
    Med Lett Drugs Ther; 2008 Nov; 50(1298):86-8. PubMed ID: 18978704
    [No Abstract]   [Full Text] [Related]  

  • 54. Controversies of thrombophylaxis following knee arthroplasty surgery.
    Campbell D; Smith P; Lewis P; Bruce W
    ANZ J Surg; 2010 Jun; 80(6):391-5. PubMed ID: 20618189
    [No Abstract]   [Full Text] [Related]  

  • 55. Duration of anticoagulation in venous thromboembolism.
    Hyers TM
    Arch Intern Med; 2003 Jun; 163(11):1265-6. PubMed ID: 12796061
    [No Abstract]   [Full Text] [Related]  

  • 56. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
    Korjian S; Daaboul Y; Halaby R; Goldhaber SZ; Cohen AT; Singh K; Susheela AT; Harrington RA; Hull RD; Hernandez AF; Gibson CM
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):227-32. PubMed ID: 26341120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum acute phase protein concentrations after hysterectomy with and without low-molecular-weight heparin thrombosis prophylaxis.
    Maciejczyk-Pencuła M; Polak G; Kotarski J
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):752-5. PubMed ID: 16026400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatal intrahepatic hemorrhage after nadroparin use for total hip arthroplasty.
    Ventura F; Bonsignore A; De Stefano F; Pizzorno E; Palmiere C
    Forensic Sci Med Pathol; 2014 Dec; 10(4):619-22. PubMed ID: 25108423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Venous thromboembolism: "... an ounce of prevention is worth a pound of cure".
    Goldhaber SZ; Ageno W
    Thromb Haemost; 2015 Jun; 113(6):1174-5. PubMed ID: 25947622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.